MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners - Seite 2

An investment in the relevant shares involves substantial risks and uncertainties. Prospective investors should read the entire Prospectus, and, in particular, should refer to the chapter "Risk Factors" beginning on page 7 of the Prospectus for a discussion of certain factors that should be considered in connection with an investment in the relevant shares, including the risks that MDxHealth's business could be materially harmed by the ongoing novel coronavirus (COVID-19) pandemic, that, taking into account its available cash and cash equivalents, MDxHealth does not have sufficient working capital to meet its present requirements and cover the working capital needs for a period of at least 12 months as of the date of this Prospectus, that MDxHealth has a history of losses, and expects to incur net losses in the future and may never achieve profitability, that the molecular diagnostics industry is highly competitive and characterized by rapid technological changes and that MDxHealth may be unable to keep pace with its competitors. All of these factors should be considered before investing in the relevant shares. Prospective investors must be able to bear the economic risk of an investment in the relevant shares and should be able to sustain a partial or total loss of their investment.

For more information:
MDxHealth
[e-mail]

Important information

The MDxHealth logo, MDxHealth, ConfirmMDx and SelectMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the Company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation. You should not place undue reliance on forward-looking statements, which reflect the opinions of MDxHealth only as of the date of this press release.